Article
Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil
18 Oct 2006
Abstract excerpt
OBJECTIVE: To assess the efficacy, safety, and pharmacokinetic interactions of ezetimibe in HIV-infected patients with poorly controlled antiretroviral-associated dyslipidaemia while taking pravastatin alone. DESIGN: A prospective, open-label, one-arm study of 24 weeks duration. PATIENTS AND SETTING: Nineteen patients (18 on stable HAART), with low density lipoprotein (LDL)-cholesterol values of > or = 130 mg/dl...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
